Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Shure hope they avoid another OO at these levels

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Jun 14, 2023 5:57pm

120 Views

Post# 35496936

RE:Shure hope they avoid another OO at these levels

Let's poll folks. At what price and amount would you be ok with them taking down some ATM at?

Let's make these assumptions: Take down next Marathon round and pay off full convert. Hit EBITDA breakeven at FY end.

How much and at what price is satisfactory to you?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec